It’s often too much for parents to absorb, especially when they’re sleep deprived and stressed. A smartphone app […]
Category: Uncategorized
By adapting techniques from the domain of artificial intelligence, such as deep learning, cognitive scientists from Osnabrück will […]
A problem with the reference list in this article by Richard Powell and colleagues (BMJ 2022;376:e065574; doi:10.1136/bmj-2021-065574) led […]
The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to […]
Beckley Psytech leads a new project focused on addressing psychiatric and neurological conditions through the use of psychedelic medicines.
AbbVie’s Skyrizi nabs psoriatic arthritis nod, its second, shortly after Rinvoq fkansteiner Mon, 01/24/2022 – 09:03
With omicron on the prowl, FDA extends inspection pause into February fkansteiner Mon, 01/24/2022 – 10:01
Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial aliu Mon, 01/24/2022 – 11:34
BDSI readies liquid migraine medicine launch but stays away from ‘broad blast’ marketing campaign sharon.coey Mon, 01/24/2022 – […]
This editorial by Peter Doshi and colleagues (BMJ 2022;376:o102, doi:10.1136/bmj.o102) originally stated that the Medicines and Healthcare Products Regulatory Agency (MHRA) […]